Research Paper Volume 15, Issue 24 pp 15134—15160
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 12. An in-depth study of COL10A1 overexpression and clinical features of PRAD. Results of the pairwise difference analysis of COL10A1 in PRAD (A). The relationship between COL10A1 overexpression in PRAD and Gleason scores and nodal metastasis (B, C).